2. Signaling Pathways
  3. MAPK/ERK Pathway
  4. p38 MAPK
  5. p38 MAPK Antagonist

p38 MAPK Antagonist

p38 MAPK Isoform Comparison

p38 MAPK Antagonists (2):

Cat. No. Product Name Effect Purity
  • HY-177156
    Glucagon receptor antagonist-8
    		Antagonist
    Glucagon receptor antagonist-8 (Compound 1) is a human glucagon receptor and p38 mitogen-activated protein (MAP) kinase antagonist, with IC50s of 0.27 μM and 0.16 μM, respectively.
  • HY-124615
    ST-162
    		Antagonist
    ST-162 is a MAPK/PI3K dual antagonist. ST-162 exhibits antitumor activity and can increase the efficacy of immune checkpoint blockers. ST-162 can be used for the research of cancer, such as melanoma.